Quality of adverse drug reaction (QADRA) reports: An algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance

被引:4
|
作者
Tuccori M. [1 ,7 ]
Giustarini G. [2 ]
Blandizzi C. [2 ]
Capogrosso-Sansone A. [2 ]
Rossi M. [3 ]
Gori G. [4 ]
Scarpini F. [5 ]
Mantarro S. [2 ]
Montagnani S. [2 ]
Vannacci A. [6 ]
Antonioli L. [2 ]
Fornai M. [2 ]
Lapi F. [6 ]
机构
[1] Adverse Drug Reaction Monitoring Unit, University Hospital of Pisa, Pisa
[2] Interdepartmental Centre for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Pisa
[3] Department of Pharmacology, University of Siena, Siena
[4] Centre of Clinical Pharmacology for Drug Experimentation, University Hospital of Pisa, Pisa
[5] Department of Internal Medicine, University Hospital of Siena, Siena
[6] Department of Pharmacology, Center for Molecular Medicine (CIMMBA), University of Florence, Florence
[7] Tuscan Regional Centre for Pharmacovigilance, Adverse Drug Reaction Monitoring Unit, University Hospital of Pisa, Via Roma 55
关键词
Adverse drug reaction; Algorithm; Pharmacovigilance; QADRA; Quality; Spontaneous reporting system;
D O I
10.1007/s10389-013-0562-y
中图分类号
学科分类号
摘要
Aim: To design and validate an algorithm for the multidimensional evaluation of the quality of adverse drug reaction (ADR) case reports (QADRA). Subject and methods: One hundred fifty-three patients randomly and retrospectively selected from 15,906 records included in the Italian database of spontaneous ADR reports throughout 2009. Each report was evaluated by two panels of experts blinded to one another as well as by the algorithm developed in the present study. Each case was classified taking three parameters into consideration: plausibility, notoriety and clinical relevance. Results: The two panels assessed that 21.6 % of reports were of "high" quality. When applying the QADRA algorithm (score range 0-15), its median value was 6 (4-7, 25 and 75 percentiles, respectively). The area under the receiver operator characteristics (ROC) curve, which assesses the ability of the risk score to predict the report quality, was 0.93 (95 % CI: 0.88-0.97). Herein, the cut-off points ≤5, 6 or 7 and ≥8 indicated the best balance between sensitivity and specificity, and they could be used to categorize the reports as being of 'high', 'intermediate' and 'low' quality (AUC = 0.87; 95 % CI: 0.80-0.92), respectively. Conclusion: The QADRA algorithm performs as a reliable and complete tool for assessing the quality of ADR reports. Several potential applications of this algorithm should be investigated in the future, both for scientific purposes and healthcare system management. © 2013 Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:365 / 372
页数:7
相关论文
共 50 条
  • [41] Spontaneous Adverse Drug Reaction Reporting in Rural Districts of Mozambique
    Sevene, Esperanca
    Mariano, Alda
    Mehta, Ushma
    Machai, Maria
    Dodoo, Alexander
    Vilardell, David
    Patel, Sam
    Barnes, Karen
    Carne, Xavier
    [J]. DRUG SAFETY, 2008, 31 (10) : 867 - 876
  • [42] Drug-induced anaphylaxis in spontaneous adverse drug reaction reports
    Sachs, B
    Schichler, D
    Riegel, S
    Erdmann, S
    Merk, HF
    [J]. EXPERIMENTAL DERMATOLOGY, 2006, 15 (03) : 188 - 188
  • [43] Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
    Caldeira, Daniel
    Rodrigues, Raquel
    Abreu, Daisy
    Anes, Ana Marta
    Rosa, Mario M.
    Ferreira, Joaquim J.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (04) : 339 - 345
  • [44] Paediatric adverse drug reactions: a review of spontaneous reports registered by a Regional PharmacoVigilance Center
    Foucras, G.
    Rousseau, V.
    Chebane, L.
    Maupiler, M.
    Durrieu, G.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 24 - 24
  • [45] Advocacy for Dedicated Pharmacovigilance Systems in Oncology to Promote the Reporting of Adverse Drug Reactions
    Quillet, P.
    Heath, D.
    Bourneau-Martin, D.
    Devys, C.
    Laine, P.
    [J]. DRUG SAFETY, 2013, 36 (09) : 803 - 803
  • [46] Healthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates
    Guner, Muherra Devrim
    Ekmekci, Perihan Elif
    [J]. JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 13 - 20
  • [47] Adverse Drug Reactions and quality deviations monitored by spontaneous reports
    Visacri, Marilia Berlofa
    de Souza, Cinthia Madeira
    Shibata Sato, Catarina Miyako
    Granja, Silvia
    de Marialva, Mecia
    Mazzola, Priscila Gava
    Moriel, Patricia
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (02) : 130 - 137
  • [48] A national viewpoint of community pharmacists of pharmacovigilance and adverse drug reaction reporting in Saudi Arabia
    Alasmari, Moudi M.
    Alsheikh, Mona Y.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 226 - 226
  • [49] Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital
    Sharma, Raghava
    Kellarai, Adithi
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (04) : 248 - +
  • [50] Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory Landscape
    Marina Lengsavath
    Anne Dal Pra
    Anne-Marie de Ferran
    Sabine Brosch
    Linda Härmark
    Victoria Newbould
    Susana Goncalves
    [J]. Therapeutic Innovation & Regulatory Science, 2017, 51 : 125 - 131